Combination Chemotherapy in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating
patients who have Burkitt's lymphoma or Burkitt's leukemia.